Developing precision medicines for well-validated targets New Insights. New Opportunities. New Therapeutics. Learn More In pursuit of best-in-class small molecule drugs to treat cancer and immunologic diseases Learn More Latest News All News XinThera Announces Appointment of Christopher LeMasters as Chief Executive OfficerPress ReleaseXinThera Mourns Loss of Founder Stephen KaldorPress ReleaseXinThera Closes $50M Series B FinancingPress Release
